UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050042
Receipt number R000056884
Scientific Title The effect of Chlorella AL-0015 to improve sleep quality.
Date of disclosure of the study information 2023/01/31
Last modified on 2023/04/06 00:27:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of Chlorella AL-0015 to improve sleep quality.

Acronym

The effect of Chlorella AL-0015 to improve sleep quality.

Scientific Title

The effect of Chlorella AL-0015 to improve sleep quality.

Scientific Title:Acronym

The effect of Chlorella AL-0015 to improve sleep quality.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the effect of continued consumption of the test food on sleep quality.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Subjective sleep assessment (Athens Insomnia Scale (AIS), Pittsburgh Sleep Questionnaire (PSQI)), VAS for fatigue, heart rate analysis during sleep (BITAS-Health care)

Key secondary outcomes

Psychological assessment of stress (POMS2), urinalysis (general urine analysis, creatinine and 8-OHdG), salivary hormone analysis (cortisol and sIgA), blood tests (common hematology and biochemistry tests)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of test foods for 8 weeks.

Interventions/Control_2

Intake of placebo foods for 8 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Those who are dissatisfied or anxious about their sleep.
(2)Men and women who are at least 20 years old and less than 65 years old (at the time of consent) at the time of obtaining written consent to participate in the study.
(3)Persons who have the necessary comprehension to consent to all tests, observations, and evaluation items specified in the study protocol, and who are able to obtain written consent based on their understanding of the contents of the study.
(4)Persons who are deemed appropriate by the investigator to participate in this study.

Key exclusion criteria

(1) Those who currently suffer from some chronic disease and are receiving drug treatment.
(including psychoneurological disorders)
(2)Persons who may show severe allergic symptoms to foods.
(3) Those who are pregnant or may become pregnant.
(4)Persons who are participating in other human clinical trials or have participated in other human clinical trials within 3 months
(5)Persons who consume excessive amounts of alcohol
(6)Those who are unable to participate in the study due to hepatic, renal, or cardiac disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes mellitus, or other diseases.
(7) Other subjects who are judged by the investigator to be inappropriate for the study.
(8)Those whose working hours vary greatly from day to day.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tomomi
Middle name
Last name Himeno

Organization

Medical Corporation Yutoku Hossinkai

Division name

Himeno Tomomi Clinic

Zip code

141-0032

Address

4F Win No.2 Gotanda Building, 4-1-2 Osaki, Shinagawa-ku, Tokyo

TEL

03-5436-7351

Email

tomomi@himeno-clinic.com


Public contact

Name of contact person

1st name Katsuyuki
Middle name
Last name Shiono

Organization

Algalbio Co., Ltd.

Division name

Business Development Group

Zip code

277-0882

Address

301 Tokatsu Techno Plaza, 5-4-6 Kashiwanoha, Kashiwa-shi, Chiba

TEL

04-7138-6207

Homepage URL


Email

shiono@algalbio.co.jp


Sponsor or person

Institute

Medical Corporation Yutoku Hossinkai

Institute

Department

Personal name



Funding Source

Organization

Algalbio Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Himeno Tomomi Clinic Ethics Committee

Address

4F Win No.2 Gotanda Building, 4-1-2 Osaki, Shinagawa-ku, Tokyo

Tel

03-5436-7351

Email

htc.ijika@himeno-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 12 Month 22 Day

Date of IRB

2022 Year 12 Month 21 Day

Anticipated trial start date

2023 Year 02 Month 01 Day

Last follow-up date

2024 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 15 Day

Last modified on

2023 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056884


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name